BioSig Technologies agrees to partnership with two Mayo Clinic electrophysiologists
BioSig Technologies announced an agreement to work with two Mayo Clinic cardiac electrophysiologists to develop features and applications for the company’s PURE EP system.
Mayo Clinic electrophysiologists Samuel Asirvatham, MD, and K. L. Venkatachalam, MD, will also contribute intellectual property and clinical support to the partnership, according to a BioSig Technologies news release on March 23.
In March 2016, the company established a research program with Asirvatham, which followed studies conducted at Mayo Clinic in March, June and November 2015. BioSig said at the time it had tripled its investment and hoped to develop features in preclinical work that could eventually help treat complex arrhythmias.
The FDA has not approved the PURE EP system, but BioSig has partnered with Minnetronix on technology development and hopes to get a 510(k) clearance to market the system in the U.S.
The system acquires and displays cardiac signal recordings that electrophysiologists can use to identify ablation targets, according to the company.
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.